Elutia (ELUT) Research & Development (2019 - 2026)
Elutia recorded quarterly Research & Development of $2.0 million in Q1 2026, up 62.39% quarter-over-quarter from $1.2 million in Q4 2025, and up 126.52% year-over-year from $871000.0 in Q1 2025.
Elutia's Research & Development history runs 8 years deep, the most recent figure standing at $2.0 million for Q1 2026.
- In Q1 2026, Research & Development rose 126.52% year-over-year to $2.0 million; the TTM figure through Mar 2026 stood at $5.7 million (up 73.64% YoY), while the FY2025 annual figure was $4.2 million, up 38.86% from the prior year.
- Research & Development came in at $2.0 million for Q1 2026 at Elutia, up from $1.2 million in the prior quarter.
- In the past five years, Research & Development ranged from a high of $2.6 million in Q2 2022 to a low of $557000.0 in Q3 2023.
- A 5-year average of $1.4 million and a median of $1.2 million in 2025 frame the typical range for Research & Development.
- Across the five-year window, Research & Development slumped 67.67% in 2023 and soared 126.52% in 2026, its largest moves.
- Elutia's Research & Development stood at $1.9 million in 2022, then fell by 25.65% to $1.4 million in 2023, then slumped by 47.43% to $727000.0 in 2024, then surged by 67.13% to $1.2 million in 2025, then soared by 62.39% to $2.0 million in 2026.
- According to Business Quant data, Research & Development over the past three periods registered $2.0 million, $1.2 million, and $1.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 767.00 Mn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 413.00 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 722.00 Mn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 516.00 Mn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 263.30 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -461.27 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 145.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 345.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 28.80 Mn |
| 10 | Elutia | 45.79 Mn | 17.31 Mn | 1.80 Mn | 1.97 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.97 Mn |
| Dec 31, 2025 | 1.22 Mn |
| Sep 30, 2025 | 1.09 Mn |
| Jun 30, 2025 | 1.46 Mn |
| Mar 31, 2025 | 905,000.00 |
| Dec 31, 2024 | 727,000.00 |
| Sep 30, 2024 | 702,000.00 |
| Jun 30, 2024 | 1.00 Mn |
| Mar 31, 2024 | 1.17 Mn |
| Dec 31, 2023 | 1.38 Mn |
| Sep 30, 2023 | 557,000.00 |
| Jun 30, 2023 | 869,000.00 |
| Mar 31, 2023 | 1.59 Mn |
| Dec 31, 2022 | 1.86 Mn |
| Sep 30, 2022 | 1.72 Mn |
| Jun 30, 2022 | 2.62 Mn |
| Mar 31, 2022 | 2.27 Mn |
| Dec 31, 2021 | 3.38 Mn |
| Sep 30, 2021 | 2.29 Mn |
| Jun 30, 2021 | 1.88 Mn |
| Mar 31, 2021 | 1.72 Mn |
| Dec 31, 2020 | 1.97 Mn |
| Sep 30, 2020 | 1.26 Mn |
| Jun 30, 2020 | 1.41 Mn |
| Mar 31, 2020 | 1.31 Mn |
| Dec 31, 2019 | 658,000.00 |
| Sep 30, 2019 | 507,000.00 |